GB201909458D0 - Optimised dosage of diaminophenothiazines in populations - Google Patents

Optimised dosage of diaminophenothiazines in populations

Info

Publication number
GB201909458D0
GB201909458D0 GBGB1909458.0A GB201909458A GB201909458D0 GB 201909458 D0 GB201909458 D0 GB 201909458D0 GB 201909458 A GB201909458 A GB 201909458A GB 201909458 D0 GB201909458 D0 GB 201909458D0
Authority
GB
United Kingdom
Prior art keywords
diaminophenothiazines
populations
optimised
dosage
optimised dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1909458.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wista Laboratories Ltd
Original Assignee
Wista Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wista Laboratories Ltd filed Critical Wista Laboratories Ltd
Priority to GBGB1909458.0A priority Critical patent/GB201909458D0/en
Priority to PCT/EP2019/069428 priority patent/WO2020020751A1/en
Priority to AU2019308873A priority patent/AU2019308873A1/en
Priority to BR112021000802-0A priority patent/BR112021000802A2/en
Priority to IL280361A priority patent/IL280361B1/en
Priority to US17/262,902 priority patent/US20210236509A1/en
Priority to MX2021000894A priority patent/MX2021000894A/en
Priority to CN201980061773.1A priority patent/CN112805008A/en
Priority to KR1020217005178A priority patent/KR20210038586A/en
Priority to CA3106152A priority patent/CA3106152A1/en
Priority to EP19752425.9A priority patent/EP3826639A1/en
Priority to SG11202100333XA priority patent/SG11202100333XA/en
Priority to JP2021502770A priority patent/JP7465861B2/en
Publication of GB201909458D0 publication Critical patent/GB201909458D0/en
Priority to US17/961,961 priority patent/US20230115931A1/en
Ceased legal-status Critical Current

Links

GBGB1909458.0A 2018-07-26 2019-07-01 Optimised dosage of diaminophenothiazines in populations Ceased GB201909458D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1909458.0A GB201909458D0 (en) 2019-07-01 2019-07-01 Optimised dosage of diaminophenothiazines in populations
CN201980061773.1A CN112805008A (en) 2018-07-26 2019-07-18 Optimal diaminophenothiazine dosage in a population
KR1020217005178A KR20210038586A (en) 2018-07-26 2019-07-18 Optimal dosage of diaminophenothiazines in the population
BR112021000802-0A BR112021000802A2 (en) 2018-07-26 2019-07-18 OPTIMIZED DOSAGE OF DIAMINOPHENOTIAZINS IN POPULATIONS
IL280361A IL280361B1 (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations
US17/262,902 US20210236509A1 (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations
MX2021000894A MX2021000894A (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations.
PCT/EP2019/069428 WO2020020751A1 (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations
AU2019308873A AU2019308873A1 (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations
CA3106152A CA3106152A1 (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations
EP19752425.9A EP3826639A1 (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations
SG11202100333XA SG11202100333XA (en) 2018-07-26 2019-07-18 Optimised dosage of diaminophenothiazines in populations
JP2021502770A JP7465861B2 (en) 2018-07-26 2019-07-18 Optimizing dosing of diaminophenothiazines in populations.
US17/961,961 US20230115931A1 (en) 2018-07-26 2022-10-07 Optimised dosage of diaminophenothiazines in populations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1909458.0A GB201909458D0 (en) 2019-07-01 2019-07-01 Optimised dosage of diaminophenothiazines in populations

Publications (1)

Publication Number Publication Date
GB201909458D0 true GB201909458D0 (en) 2019-08-14

Family

ID=67539916

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1909458.0A Ceased GB201909458D0 (en) 2018-07-26 2019-07-01 Optimised dosage of diaminophenothiazines in populations

Country Status (1)

Country Link
GB (1) GB201909458D0 (en)

Similar Documents

Publication Publication Date Title
IL280361A (en) Optimised dosage of diaminophenothiazines in populations
IL264210A (en) High-strength oral cannabinoid dosage forms
GB2594345B (en) Single dosage shampoo
HRP20210144T8 (en) Compositions comprising an inhibitor of lysine specific demethylase-1 having a pyrimidine ring and its use in the treatment of cancer
EP3302442A4 (en) Dosage forms and use thereof
GB201913857D0 (en) Computing circuitry
EP3265115A4 (en) USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
HK1255193A1 (en) Optimised high-dose mesalazine-containing tablet
IL277792A (en) Pharmaceutical compositions with reduced tert-butanol levels
GB2583782B (en) Computing circuitry
IL269169A (en) Novel dosage form
GB201909458D0 (en) Optimised dosage of diaminophenothiazines in populations
GB201812193D0 (en) Optimised dosage of diaminophenothiazines in populations
EP3341481A4 (en) Microrna-328 anti-sense composition and therapeutic use
EP3167870C0 (en) Tamperproof oral dosage form
GB2582381B (en) Undergarments
EP4025186A4 (en) Nucleic acid-mediated delivery of therapeutics
GB201919240D0 (en) Optimised charging
GB201917327D0 (en) New pharmaceutical use
GB201913328D0 (en) New Pharmaceutical use
GB201905298D0 (en) Improvements in delivery devices
GB201808473D0 (en) Dosage regime
GB201808507D0 (en) Dosage Regime
GB201808101D0 (en) Dosage regime
GB201803298D0 (en) Dosage regime

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)